SCHEMBL5281318

SCHEMBL5281318

Nc1ncnn2cc(C(=O)O)c(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 14/20 0.55
AURKB Q96GD4 7/20 0.55
KIT P10721 7/20 0.55
AURKA O14965 6/20 0.55
TEK Q02763 3/20 0.55
CDK19 Q9BWU1 1/20 0.55
FLT3 P36888 7/20 0.52
LCK P06239 5/20 0.52
LYN P07948 5/20 0.52
BLK P51451 5/20 0.52
NTRK1 P04629 4/20 0.52
NTRK2 Q16620 4/20 0.52
MARK2 Q7KZI7 4/20 0.52
CDK1 P06493 3/20 0.52
MARK3 P27448 3/20 0.52
RPS6KA3 P51812 3/20 0.52
STK3 Q13188 3/20 0.52
ROCK1 Q13464 3/20 0.52
JAK3 P52333 3/20 0.52
FYN P06241 3/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5276553 0.91 KDR (0.51) KDRAURKBKITAURKATEK
SCHEMBL275915 0.88 BTK (0.46) KDRAURKBKITAURKATEK
SCHEMBL3621547 0.88 KDR (0.54) KDRAURKBKITAURKATEK
SCHEMBL275916 0.87 KDR (0.57) KDRAURKBKITAURKATEK
SCHEMBL14420667 0.87 KDR (0.54) KDRAURKBKITAURKATEK
SCHEMBL3618935 0.86 FLT1 (0.55) KDRAURKBKITAURKATEK
SCHEMBL27663171 0.86 KDR (0.53) KDRAURKBKITAURKATEK
SCHEMBL5276476 0.86 RIPK1 (0.52) KDRAURKBKITAURKAFLT3
SCHEMBL5276575 0.85 AURKA (0.44) KDRAURKBKITAURKATEK
SCHEMBL3625505 0.85 RIPK1 (0.53) KDRAURKBKITAURKATEK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1765823-A1 PYRROLOTRIAZINE DERIVATIVES USEFUL FOR TREATING HYPER-PROLIFERATIVE DISORDERS AND DISEASES ASSOCIATED WITH ANGIOGENESIS Bayer Pharmaceuticals Corporation (US) 2007-03-28 EP disclosed
WO-2005121147-A1 PYRROLOTRIAZINE DERIVATIVES USEFUL FOR TREATING HYPER-PROLIFERATIVE DISORDERS AND DISEASES ASSOCIATED WITH ANGIOGENESIS BAYER PHARMACEUTICALS CORPORATION (US) 2005-12-22 WO disclosed